Wed, March 23, 2011
[ Wed, Mar 23rd 2011 ] - Market Wire
Gilead to Offer Senior Notes
Tue, March 22, 2011
Mon, March 21, 2011
[ Mon, Mar 21st 2011 ] - Market Wire
30 p.m. ET
Sun, March 20, 2011
Fri, March 18, 2011
Thu, March 17, 2011
Wed, March 16, 2011
Tue, March 15, 2011
Mon, March 14, 2011
[ Mon, Mar 14th 2011 ] - Market Wire
30 AM E.T.
Sun, March 13, 2011
Sat, March 12, 2011
Fri, March 11, 2011
[ Fri, Mar 11th 2011 ] - Market Wire
Covidien????????????????FDA??
Thu, March 10, 2011
Wed, March 9, 2011
Tue, March 8, 2011
Mon, March 7, 2011
Sat, March 5, 2011
Fri, March 4, 2011
Thu, March 3, 2011

Obagi Medical Products to Present at the 23rd Annual Roth OC Growth Stock Conference


//health-fitness.news-articles.net/content/2011/ .. 23rd-annual-roth-oc-growth-stock-conference.html
Published in Health and Fitness on Friday, March 11th 2011 at 6:05 GMT by Market Wire   Print publication without navigation


LONG BEACH, Calif.--([ BUSINESS WIRE ])--Obagi Medical Products, Inc. (NASDAQ: OMPI), a leader in topical aesthetic and therapeutic skin health systems, today announced that Preston Romm, the Companya™s Chief Financial Officer and EVP, Finance, Operations and Administration, will present a corporate overview at the 23rd Annual Roth OC Growth Stock Conference to be held at the Ritz Carlton Hotel in Dana Point, California. The presentation will take place at 2:00 p.m. (PDT) on Tuesday, March 15, 2011.

A live webcast of the presentation will be available via the internet by visiting the Investor Relations section of the Company's web site at [ www.obagi.com ]. The archived presentation will be available on the web site for 30 days.

About Obagi Medical Products, Inc.

Obagi Medical Products is a specialty pharmaceutical company that develops, markets and sells, proprietary topical aesthetic and therapeutic prescription-strength skin care systems in the physician-dispensed market. Using its Penetrating Therapeuticsa" technologies, Obagi Medical's products are designed to improve penetration of agents across the skin barrier for common and visible skin conditions in adult skin including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, facial redness, and soft tissue deficits, such as fine lines and wrinkles. The history of Obagi's skin care product introductions is as follows: Obagi Nu-Derm®, Obagi-C® Rx (a prescription-strength vitamin C and hydroquinone system), Obagi® Professional-C (a line of highly stable vitamin C serums), Obagi Condition & Enhance® for use with cosmetic procedures to enhance patient outcomes and satisfaction, Obagi ELASTIderm® Eye Treatment and Obagi CLENZIderm® M.D. acne therapeutic systems, a formulation of Obagi CLENZIderm M.D. Systems for normal to dry skin, and Obagi ELASTIderm D©colletage System, Obagi Rosaclear® System, Obagi ELASTILasha" Eyelash Solution, Obagi Blue Peel RADIANCEa", and Nu-Derm® Sun Shield SPF 50. Visit [ www.obagi.com ] for more information.


Publication Contributing Sources